UCM.AU Uscom Ltd

Healthcare Health Care Equipment & Supplies Australian Securities Exchange
0.0120 AUD
Close of Mar 9, 2026
0.0120 0.0120
Market cap
AUD 3.12M
P/E
-
P/B
2.16x
ROE
1,797.0%
Dividend yield
-
Fundamental score
1.8/5

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Dec 2025.

Is UCM.AU undervalued?

Graham number

The Graham number of Uscom Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Uscom Ltd fundamental analysis

8 of 22 checks passed

ROE 2/2

High return on equity (1,797.0%), above 20%.

ROA 1/1

Return on assets (712.7%) is above the industry median (-35.3%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-51.4%) is below the industry median (24.9%).

Revenue Growth 1/2

Revenue grew 0.9% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (11.5%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 0/1

EBIT is negative, against interest expense, below 5x.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (2.2x) is below the industry median (4.0x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Uscom Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Uscom Ltd

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. The company also provides the Spir…

Full company profile